Project Grant R01AI179722
- This federal Project Grant award of $3,161,373 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research on the transmission dynamics and fitness of the reemerging St. Louis encephalitis virus (SLEV) in mosquito vectors and West Nile virus (WNV) naive and immune avian reservoirs. The research aims to understand the reasons for SLEV's 11-year disappearance from California and its recent...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 2-year, $544,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Texas Biomedical Research Institute to characterize a novel mouse model for studying the neurological impacts of Chikungunya virus infection. The research aims to determine the mechanisms by which Chikungunya virus infects the brain and evaluate whether the mouse model develops the...
- This $116,766 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at Rutgers, The State University to define the long-term neurological consequences of asymptomatic Zika virus (ZIKV) infection. The research team has developed an immunocompetent mouse model of systemic ZIKV infection in which infected animals do not display...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $530,385.00 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to conduct research on how host cell factors regulate the activity of the essential flaviviral enzyme NS3 in viral pathogens like dengue, Zika, and West Nile viruses. The research aims to define in detail how...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $431,750 R21 project grant (CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders) to Rutgers, The State University of New Jersey to study the role of the RIPK3 protein in protecting neurons from excitotoxicity during Zika virus infection. The two-year project will use a combination of pharmacogenetics, imaging, molecular biology, and electrophysiology to investigate how RIPK3...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to decipher the role of the chemokine receptor CCR5 in protecting against flavivirus infections during pregnancy. The $3,021,038 grant, awarded on September 2, 2025, will fund a study to investigate the mechanisms by which CCR5 provides neuroprotection against West Nile virus, Zika virus, and other...
- This three-year $872,936 project grant from the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, will fund research into the regulation of the microglial neuroimmune response by long non-coding RNAs. The grantee, Creighton University, will investigate how specific long intergenic non-coding RNAs (lincRNAs) mediate a proinflammatory state in microglia and determine if differential lincRNA expression underlies viral-induced mouse models of...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $648,924 Project Grant to Iowa State University of Science and Technology under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The project, titled "Mosquito Extracellular Vesicles in Malaria Parasite Killing and Immune Priming," aims to obtain a mechanistic understanding of the role of mosquito extracellular vesicles in the mosquito immune system's recognition and killing of...
- This Project Grant award, totaling $155,454, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in Missouri. The award supports research to identify alternative receptors and improve therapeutic decoy molecules for Venezuelan Equine Encephalitis Virus (VEEV), a mosquito-borne virus that causes severe neurological symptoms. The key products and services to be...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $281,786 to L2 Diagnostics LLC for the development of a safe and effective viral vector-based vaccine to induce both humoral and cellular immune protection against Powassan virus. The goal is to leverage the Modified Vaccinia Ankara vector platform to stimulate robust antibody and T cell responses that...
INNATE IMMUNITY TO WEST NILE VIRUS - WEST NILE VIRUS (WNV) IS A FLAVIVIRUS OF GLOBAL CONCERN AND SERVES AS MODEL FLAVIVIRUS. WNV IS TRANSMITTED TO HUMANS VIA THE BITE OF AN INFECTED MOSQUITO, AND INFECTION IS ACCURATELY MODELED IN IMMUNOCOMPETENT MICE. DURING ACUTE INFECTION, WNV REPLICATES IN SHORT-LIVED PERIPHERAL MYELOID CELLS AND CAN SPREAD TO LONG-LIVED PARENCHYMAL CELLS OF MANY TISSUES UNLESS RESTRICTED BY THE INNATE IMMUNE RESPONSE. THOSE WHO RECOVER FROM INFECTION OFTEN EXPERIENCE LONG-TERM SEQUELAE INCLUDING PERSISTENT INFLAMMATION AND COGNITIVE DECLINE. WNV CAN INVADE THE CENTRAL NERVOUS SYSTEM (CNS) AND CAUSE DEATH. BOTH INNATE AND ADAPTIVE IMMUNITY ARE ESSENTIAL FOR CONTROL OF WNV AND CNS INVASION, BUT HOW THESE RESPONSES ARE INITIATED AND PROGRAMMED FOLLOWING MYELOID CELL ACUTE INFECTION ARE NOT WELL UNDERSTOOD. OUR STUDIES SHOW THAT THE RIG-I-LIKE RECEPTORS (RLRS), RIG-I AND MDA5, PLAY ESSENTIAL ROLES IN RECOGNITION OF WNV IN MYELOID CELLS. OUR PRELIMINARY STUDIES NOW INDICATE THAT RIG-I AND MDA5 SENSE AND BIND TO SPECIFIC PATHOGEN ASSOCIATED MOLECULAR PATTERN (PAMP) MOTIFS WITHIN WNV GENOMIC AND REPLICATION STRAND RNA PRODUCTS TO TRIGGER THE INNATE IMMUNE RESPONSE IN MYELOID CELLS. USING NOVEL RIG-I AND MDA5 CONDITIONAL KNOCKOUT MICE LACKING EITHER FACTOR IN MYELOID CELLS, WE REVEAL THAT THE RLRS DIRECT A MYELOID CELL RESPONSE THAT SERVES TO RESTRICT SYSTEMIC VIRUS REPLICATION; MYELOID CELL SIGNALING BY RLRS DIRECTS AN INNATE IMMUNE RESPONSE THAT SERVES TO SUPPRESS VIRUS SPREAD, INDUCE TYPE I AND III INTERFERONS, AND PROTECT AGAINST CNS INVASION. IMMUNOLOGICAL ANALYSES INDICATE THAT RLR SIGNALING IN MYELOID CELLS PLAYS AN IMPOTENT ROLE TO PROGRAM THE ADAPTIVE IMMUNE RESPONSE FOR CLEARANCE OF INFECTION. USING AN INFECTED CELL-REPORTER MOUSE MODEL WE HAVE IDENTIFIED PREVIOUSLY INFECTED WNV-EXPERIENCED CELLS INCLUDING CNS NEURONS, FOLLOWING VIRUS CLEARANCE. FUNCTIONAL GENOMICS ANALYSES OF WNV-INFECTED MYELOID CELLS, AND SPATIAL TRANSCRIPTIONAL PROFILING OF TISSUE REGIONS OF THE WNV-EXPERIENCED CELLS, SHOW SIGNATURES OF INNATE AND ADAPTIVE IMMUNE PROGRAMMING THAT PRECEDE LONG-TERM INFLAMMATORY SIGNATURES OF WNV SEQUELAE. THUS, WNV PAMP SENSING AND INNATE AND ADAPTIVE IMMUNE ACTIONS LEAD TO OUTCOMES OF VIRUS CONTROL AND INFECTION SEQUELAE BUT THE MOLECULAR MECHANISMS PROGRAMMING THESE OUTCOMES ARE NOT DEFINED. THE PROPOSED STUDIES WILL INVESTIGATE THE HYPOTHESIS THAT RLR- MEDIATED SENSING OF WNV WITHIN SHORT-LIVED, REPLACEABLE MYELOID CELLS INITIATES INNATE IMMUNE RESPONSE THAT PREVENTS VIRAL SPREAD AND NEUROINVASION, WHICH PARENCHYMAL CELLS THAT SURVIVE VIRAL INFECTION CAN DRIVE LONG-TERM INFLAMMATORY SEQUELAE DUE TO UNRESOLVED INFLAMMATORY SIGNALING THAT REMAINS AFTER VIRAL CLEARANCE. WE WILL CONDUCT THE FOLLOWING SPECIFIC AIMS: 1: DEFINE THE WNV PAMP LIGANDS OF RIG-I AND MDA5, AND DETERMINE PAMP- INDUCED INNATE IMMUNE ACTIVATION PROGRAMS; 2: DETERMINE THE MYELOID CELL-SPECIFIC ROLE OF RLRS IN INNATE IMMUNE PROTECTION AND IMMUNE PROGRAMMING AGAINST WNV INFECTION. 3: IDENTIFY THE DETERMINANTS BY WHICH WNV INFECTION PROMOTES SEQUELAE ACROSS TISSUES. THIS WORK WILL PROVIDE IMPORTANT INSIGHT INTO THE VIRUS AND HOST FEATURES OF IMMUNE PROGRAMMING AND POST-INFECTION SEQUELAE FROM INFECTION BY WNV AND OTHER FLAVIVIRUSES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $881.5k | 6/4/25 | ||
| Not listed | $0 | 10/23/24 | ||
| Not listed | $0 | 10/23/24 | ||
| Not listed | $88.2k | 9/4/24 | ||
| Not listed | $88.2k | 9/4/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
UWSC16086S | Regents Of The University Of Minnesota | Project Grant R01AI179722 | $411.9k | 4/17/25 |